| Animals and experimental design
All SD rats (160-200 g) were obtained from the department of animal science, Medical College of Nanchang University. All animals received humane care, and the experimental protocol was approved by the Committee of Laboratory Animals and was performed according to institutional guidelines. All animals were kept in an environmentally controlled room (23 ± 2°C, 55 ± 10% humidity) with a 12 hr light/dark cycle, and they were allowed free access to food and water.
After a 1-week housing period, seventy-two SD rats were randomly divided into six groups: blank control group, liver fibrosis model group, apocynin prevention group, apocynin treatment group, UA prevention group, or UA treatment group. For the liver fibrosis model group, we gave rats an intragastric administration of carbon tetrachloride (CCl4) for 8 weeks at 2 ml/kg (20% olive oil dilution concentration) twice a week. For rats in the prevention groups, 2 weeks after gavaging with CCl4, we gavaged the rats with apocynin or UA (40 mg/kg/day) for the last 6 weeks at the same time. For rats in the treatment groups, we gavaged the rats with apocynin or UA for another four weeks alone, 8 weeks after gavaging with CCl4.
At the end of treatment, eight rats in each group were used for the biochemical analysis and histological evaluations. Rats were sacrificed, and blood samples of approximately 5 ml were drawn through a postcava puncture with vacuum blood collection tubes. The plasma was collected after centrifugation at 5,000 rpm for 10 min and stored in a −70°C freezer for further analysis. The liver tissues were rinsed in ice-cold 0.9% NaCl solution and stored in a −70°C freezer for later use.
Four rats in each group were used for extracting primary HSCs, HCs and KCs, in situ perfusion and gradient centrifugation. The rats were anesthetized by an intraperitoneal injection of 10% chloral hydrate. We perfused phosphate buffered saline (PBS) through the inferior vena cava, and cut open the portal vein at the same time.
According to various densities in those three kinds of cells, we then separated HCs, HSCs, and KCs using Collagenase IV (Gibco, Grand Island, NY, UA), Pronase E (Sigma Immunochemicals, St. Louis, MO, UA) and Precoll (Sigma) successively. HCs and HSCs were cultured in Dulbecco's modified essential medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) in humidified air containing 5% CO 2 at 37°C; however, KCs were cultured in 1640 medium (Gibco) supplemented with 10% FBS (Gibco) in humidified air containing 5% CO 2 at 37°C.
| Blood and liver tests
The alanine aminotransferase (ALT), total bilirubin (TBIL), albumin (ALB), white blood cell (WBC), C-reactive protein (CRP), and procalcitonin (PCT) contents of serum were estimated using an automatic biochemical analyzer (Department of clinical laboratory, the First Affiliated Hospital of Nanchang University, China). The malondialdehyde (MDA) and hydroxyproline (HYP) contents of serum or liver tissue were tested spectrophotometrically using commercial diagnostic kits.
| Histological evaluations
Liver samples fixed in 10% buffered formalin were embedded in paraffin, cut into 5 µm sections, stained with hematoxylin and eosin (H&E), Sirius red, TdT-mediated dUTP Nick-End Labeling (TUNEL, to detect the apoptosis of HCs in liver tissue), or for immunohistochemistry (IHC, to detect proliferating cell nuclear antigen, PCNA) analysis before being observed and photographed using light microscopy.
For the semi-quantitative of TUNEL and PCNA expression, we used a scoring method as follows. The percentage of positive HCs in liver tissue was determined in at least five areas at ×400 magnification and assigned to one of the following categories: 0 = <5%; 1 = 6-49%; 2 = 50-75%; 3 > 75% (Table A below) . The staining intensity of the nucleus were scored as 0 point (uncolored), 1 point (light yellow), 2 point (brown), 3 point (tan) ( Table B below) . Finally, according to the products of the positive cells percentage and the staining intensity score, the results were decided.
| Western blot analysis
Liver tissue protein was obtained using protein lysate (BestBio, Shanghai, China) for Western blotting. Cells were harvested and resuspended in PBS. Cell protein extracts were obtained by centrifuging at 12,000 rpm for 10 min. Protein levels were determined using the BCA assay kit (Tiangen, Beijing, China). Protein extracts (10-20 ml) were separated using 6-12% sodium dodecyl sulfate polyacrylamide gel electrophoresis, and electrophoretically transferred onto polyvinylidene fluoride membranes. After blocking with 5% nonfat dry milk in Tris-buffered saline, PVDF membranes were incubated overnight at 4°C with rabbit anti-NOX1 (1:1000), anti-NOX2 (1:1000), anti-NOX4
(1:1000), anti-TGFβ1 (1:2000), anti-MMP1 (1:2000), anti-TIMP1
(1:2000), anti-p67phox (1:500), anti-p22phox (1:500), anti-p47phox
(1:500), anti-caspase-3 (1:1000), anti-caspase-9 (1:1000), anti-GADD45 (1:1000), anti-Bcl2 (1:800), anti-Bax(1:1000), anti-CD95L
(1:200), anti-CD95 (1:3000), anti-XIAP (1:2000), or mouse anti-α-SMA (1:200), anti-rac1(1:750), anti-collagenase I (1:1000). Next, a secondary horseradish peroxidase-conjugated anti-rabbit or antimouse IgG antibody (Zhongshan Golden Bridge Biotechnology Co., Beijing, China) was applied, and specific bands were visualized using an ECL detection kit (Thermo Fisher Scientific Inc).
| RNA preparation
Total liver RNA was prepared from frozen tissue samples or cells using a RNA simple Total RNA Kit and a Fast Quant RT Kit (Tiangen, Beijing, China). The concentration and purity of isolated RNA were determined by measuring optical density at 260 and 280 nm. The integrity of the RNA was verified using agarose gel electrophoresis (AGE).
| RT-qPCR
For reverse transcription-polymerase chain reaction (RT-PCR), we used the experimental procedure from the Fast Quant RT Kit and the Super Real Pre-Mix Plus (SYBR Green, tiangen, Beijing, China). The primer sets were as follows ( 4. Centrifuge at 50g for 5 min, and the cell was collected.
5. The cells were resuspended in PBS, and centrifuged again (50g, 5 min).
6. The cells were suspended in DMEM conditioned medium and cultured overnight in a humidified air containing 5% CO 2 at 37°C. 2. After digestion, the tissue was mechanical separated softly until there was no obvious tissue mass.
3. Centrifuge at 50g for 3 min, and the supernatant was collected.
4. The supernatant was centrifuged at 500g for 5 min, and the sediment was collected.
5.
The sediment was resuspended in PBS. We slowly added to the upper layer of well-prepared separating medium with 70% and 30% Precoll non-continuous gradient.
6. Centrifuge at 900g for 15 min. All layers of cells were aspirated slowly. The junction of 70% and 30% were KCs and liver sinusoidal endothelial cells, and upper 30% layer were HSCs.
7. For HSCs, resuspended in DMEM and centrifuge at 500g for 5 min,
The sediment was resuspended in DMEM again and cultured overnight in a humidified air containing 5% CO 2 at 37°C. 1. The slides in the culture plate which had climbed with cells were immersed in PBS for three times, 3 min at a time.
2. Fix the slides with 4% paraformaldehyde for 15 min, and then wash the slides with PBS for three times, 3 min at a time.
3. Permeate the slides with 0.5% Triton X-100 (prepared with PBS) at room temperature for 20 min.
4. The slides were immersed in PBS for three times, 3 min at a time.
Blot PBS with absorbent paper, and drop normal goat serum on the slides, blocking at room temperature for 30 min. 2.9.2 | Identification of primary HCs (by schiff periodic acid shiff, PAS)
1. The slides in the culture plate which had climbed with cells were immersed in PBS for three times, 3 min at a time.
3. Soak the slides with 1% periodic acid aqueous solution for 10 min.
Wash the slides with PBS for 2 min. 2.11 | Test host defense function of KCs 2.11.1 | Carbon particle clearance test detected the phagocytic function of KCs 1. Rats in each group were injected with ink (Carbon suspension, 10 ml/kg) in the tail vein 1 hr before the rats were sacrificed.
2. Then, 20 µl blood was collected from the eyeball of rats at 1, 5, 10 min, respectively. The blood was dissolved in 2 ml 0.1% of Na 2 CO 3 solution.
3. The absorbance (A value) was measured at 650 nm with a spectrophotometer.
4. Weigh the wet weight of liver and spleen, calculate clearance index K and phagocytic index α based the formula:
2.12 | Detection of bacterial infection
Peripheral blood (from eyeball) was taken weekly after drug treatment, and white blood cell (WBC), C-reactive protein (CRP), and procalcitonin (PCT) in serum were estimated. Lipopolysaccharides (LPS) was tested by ELISA kit.
| Statistical analysis
All statistical analyses were performed using the SPSS software, version 17.0. Data were expressed as the means ± SEM. Statistical differences between means were determined using analysis of CCl4 group compared to all other groups, respectively; *p < 0.05, **p < 0.01, ***p < 0.001 fibrous septum, deposition of collagen fibers, and formation of a pseudolobe. After UA or AP intervention, the listed visible liver histology injuries were alleviated. Disorder in the hepatic lobular structure, fibrous space and collagen deposition in liver tissue were also significantly lower after prevention or treatment compared to the CCl4 group. Indeed, quantitative analysis demonstrated a significant reduction in the fibrotic score and area (Figures 1c and 1d) . The hydroxyproline contents of rat serum and hepatic tissue declined compared to the CCl4 group (Figures 1e and 1f) .
Nevertheless, there was no significant difference between the UA treatment group and the AP treatment group (p > 0.05), nor was there a significant difference between the UA prevention group and AP prevention group (p > 0.05). Those results showed that UA could alleviate CCl4-induced liver fibrosis.
3.2 | The effect of UA intervention on liver function and oxidative stress
We measured the alanine aminotransferase (ALT), total bilirubin (TBIL), albumin(ALB), and malondialdehyde (MDA) contents of rats serum or liver tissue. CCl4 treatment resulted in high expression of ALT (Figure 2a) , TBIL (Figure 2b ), MDA (Figures 2d and 2f) , and low expression of ALB (Figure 2c) . After UA or AP intervention, the expression of the listed targets was reduced. Nevertheless, there was no significant difference between the UA treatment group and the AP treatment group (p > 0.05), nor was there a significant difference between the UA prevention group and AP prevention group (p > 0.05).
We concluded that UA could alleviate CCl4-induced hepatic dysfunction and oxidative stress.
3.3 | The effect of UA intervention on proliferation and apoptosis in HCs
Subsequently, the effect of UA intervention on proliferation and apoptosis of HCs was evaluated. We used immunohistochemistry (IHC) to detect proliferating cell nuclear antigen (PCNA) in liver tissue (Figure 3a) . We utilized TdT-mediated dUTP Nick-End Labeling (TUNEL) staining to detect apoptosis in HCs (Figure 3b ). CCl4 treatment led to increased apoptosis in HCs, and it led to decreased proliferation of HCs; After UA or AP intervention, the proliferation of HCs was increased, and apoptosis in HCs was decreased. The PCNA 
| The effect of UA intervention on genes and proteins related to fibrosis
The effect of UA on the expression of type I collagen, TGF-β1, MMP-1, and TIMP-1 genes and proteins in liver tissue was tested. As shown in 
| The effect of UA intervention on NOX proteins in liver tissue
Recent studies have indicated that NADPH oxidases (NOXs) play an important role in the pathogenesis of liver fibrosis .
We speculated that UA relieved liver fibrosis by reducing the CCl4 group compared to all other groups, respectively; *p < 0.05, **p < 0.01, ***p < 0.001 expression of NOXs. The effect of UA on the expression of NOX4, p67phox, NOX2, p47phox, NOX1, p22phox, and Rac1 proteins were detected in liver tissue. As shown in Figure 5a- (Paik et al., 2014) . We wanted to explore the effect of UA intervention on the expression of NOX mRNAs in HSCs, HCs, and KCs in vivo. We used in situ perfusion and gradient centrifugation to extract primary HSCs, HCs, and KCs from rats. We then utilized a glycogen staining assay kit to identify primary HCs, and we used Immunofluorescence (IF) to identify primary HSCs and KCs. As shown in Figure 6 (the first row), HCs contain abundant glycogen. After PAS dyeing, the cytoplasm became purple; α-SMA, and DAPI dual-positive cells were 
| Safety research about UA to reverse liver fibrosis
We wanted to know the effect of UA on host defense function. We used the carbon particle clearance test to assess the effect of UA on phagocytosis in KCs. In contrast to rats in the CCl4 group, the phagocytic index α (Figure 9b ) and clearance index K (Figure 9c ), which represent phagocytosis in KCs, were unchanged in the UA or AP prevention group.
However, phagocytosis of KCs in the UA or AP treatment group had an advantage over the CCl4 group. There was no significant change in WBC 
| DISCUSSION
Hepatic fibrosis is caused by various pathogeneses, and it lead to extracellular matrix deposition or scar formation. The sustainable development of liver fibrosis can eventually develop into liver cirrhosis, or even liver cancer, which can threaten human health (Thompson et al., 2015; Zhang & Friedman, 2012) . Although, early antiviral therapy can reverse liver fibrosis in patients with HBV and HCV infection (D'Ambrosio et al., 2012; Marcellin et al., 2013) , for other causes of liver fibrosis and cirrhosis, there are still no effective anti-fibrosis drugs applied to clinical treatment (Sun & Kisseleva, 2015) , Therefore, developing anti-liver fibrosis drugs is highly significant (Lee, Wallace, & Friedman, 2015) . We used fibrotic rats as research subjects, and apocynin (AP) (Rahman et al., 2017) as a positive control, and we observe the effect of UA intervention (UA prevention and treatment) on reversing liver fibrosis. Compared to the liver fibrosis group, the fibrous septum and collagen deposition were reduced in the liver tissue . Paik et al. (2011) found that NOX1 or NOX2 gene knockout in mice decreased ROS production, and alleviated CCl4 or bile duct ligation-induced liver fibrosis. Lan, Kisseleva, and Brenner (2015) showed that the NOX1/4 double inhibitor GKT137831, or the NOX1/4 gene knockout could reduce the formation of ROS and the expression of inflammation-related genes and block liver fibrosis. Qiu et al. (2016) showed that AP, the non-specific blocking agent of NOXs, could stop atrial remodeling, and prevent myocardial fibrosis, CCl4 group compared to all other groups, respectively; *p < 0.05, **p < 0.01, ***p < 0.001 (Jiang et al., 2010) showed that inhibiting the activation of NOX2 could inhibit the activation of HSCs. In this study, the expression of NOX4, p67phox, NOX2, p47phox, NOX1, p22phox, and Rac1 proteins in liver tissue were decreased after UA or AP intervention ( (Possamai, Thursz, Wendon, & Antoniades, 2014; Tacke, 2017; Tacke & Zimmermann, 2014) . In this study, the expression of NOX4, p67phox, NOX2, p47phox, NOX1, p22phox, and Rac1 genes ( Figure 6d ) in KCs was also reduced compared to the liver fibrosis group. This was accompanied by a reduction in activated KCs; The phagocytic index α and clearance index K which represent phagocytosis of KCs were unchanged in the UA or AP prevention group ( Figures 9b and 9c) ; but phagocytosis of KCs in UA or AP treatment group had an advantage over the CCl4 group. These results indicated that UA could lighten liver fibrosis by reducing the activation of KCs, and partially improve phagocytosis of KCs.
In the end, we discussed the effects of UA on bacterial infection and systemic inflammation during anti-hepatic fibrosis. We found that there was no significant change in WBC, LPS, or CRP between the CCl4 group and the other groups. CCl4 treatment induced the overexpression of PCT; After UA or AP intervention, PCT was reduced (Figures 9a and 9d-f ). This showed that UA could be applied to safely alleviate CCl4-induced rats liver fibrosis.
In conclusion, UA induces the proliferation of HCs, promotes apoptosis in HSCs, and prevents activation of KCs in vivo by reducing the expression of NOXs/ROS in HCs, HSCs, KCs. UA also partially improves phagocytosis of KCs, but it has no effect on the host defense function. The molecular mechanisms that undergird the effect of UA on liver fibrosis require further investigations, and future approaches toward clinical applications of UA need to be done too.
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